Literature DB >> 22477368

Serum biochemical changes in rabbits on a regular diet with and without flax lignan complex following a high-cholesterol diet.

Kailash Prasad1.   

Abstract

BACKGROUND: Flax lignan complex (FLC) isolated from flaxseed suppresses development of hypercholesterolemic atherosclerosis. It does not produce regression of atherosclerosis, but prevents its regular diet-induced acceleration following a high-cholesterol diet. It is not known if replacement of a high-cholesterol diet with a regular diet has deleterious effects on body organs.
OBJECTIVES: To determine if short-term use of a high-cholesterol diet, and a regular diet with or without FLC following the high-cholesterol diet, have any adverse effects on serum electrolytes, glucose and enzymes related to the liver, kidneys, skeletal muscle and intestines.
METHODS: Blood samples were collected from the rabbits before and at various intervals during the high-cholesterol diet, and while on the regular diet with or without FLC, following the high-cholesterol diet. Measurements of serum total cholesterol, glucose, aspartate aminotransferase (AST), alkaline phosphatase (ALP), alanine aminotransferase (ALT), gamma-glutamyltransferase (GGT), albumin, creatinine, electrolytes (sodium [Na], potassium [K], chloride [Cl]) and carbon dioxide (CO(2)) were taken.
RESULTS: The high-cholesterol diet produced hypercholesterolemia, which was associated with reductions in serum glucose and no significant changes in serum Na, K, Cl, CO(2), ALT, ALP, AST, GGT, albumin or creatinine. Regular diet with or without FLC, following the high-cholesterol diet, reduced serum total cholesterol and glucose, increased serum Na, Cl and creatinine, but produced no significant alterations in serum K, CO(2), ALT, AST, GGT or albumin. FLC reduced serum ALP, but regular diet produced no significant change.
CONCLUSION: Short-term use of a high-cholesterol diet, or a regular diet with or without FLC following the high-cholesterol diet, does not produce deleterious effects in the liver, kidneys, skeletal muscle, intestine or bone, as shown by changes in serum electrolytes, glucose and enzymes.

Entities:  

Keywords:  Alanine aminotransferase; Albumin; Alkaline phosphatase; Aspartate aminotransferase; Cholesterol; Creatinine; Flax lignan complex; Gamma-glutamyltransferase; Glucose; Serum electrolytes

Year:  2008        PMID: 22477368      PMCID: PMC2728377          DOI: 10.1055/s-0031-1278276

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  14 in total

1.  Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study.

Authors:  Hiroshi Mabuchi; Atsushi Nohara; Junji Kobayashi; Masa-aki Kawashiri; Shoji Katsuda; Akihiro Inazu; Junji Koizumi
Journal:  Atherosclerosis       Date:  2007-08-06       Impact factor: 5.162

2.  Effects of 3-hydroxy-3-methylglutaric acid on plasma and low-density lipoprotein cholesterol levels in familial hypercholesterolemia.

Authors:  P J Lupien; S Moorjani; D Brun; I Bielmann
Journal:  J Clin Pharmacol       Date:  1979 Feb-Mar       Impact factor: 3.126

3.  Curcumin attenuates diet-induced hypercholesterolemia in rats.

Authors:  Hossam M M Arafa
Journal:  Med Sci Monit       Date:  2005-06-29

4.  Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flaxseed.

Authors:  Kailash Prasad
Journal:  Atherosclerosis       Date:  2005-01-26       Impact factor: 5.162

5.  Suppression of hypercholesterolemic atherosclerosis by pentoxifylline and its mechanism.

Authors:  Kailash Prasad; Paul Lee
Journal:  Atherosclerosis       Date:  2006-09-11       Impact factor: 5.162

6.  Fatty infiltration of liver in hyperlipidemic patients.

Authors:  N Assy; K Kaita; D Mymin; C Levy; B Rosser; G Minuk
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

7.  Antioxidant Activity of Secoisolariciresinol Diglucoside-derived Metabolites, Secoisolariciresinol, Enterodiol, and Enterolactone.

Authors: 
Journal:  Int J Angiol       Date:  2000-10

8.  Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia.

Authors:  Apostolos Hatzitolios; Christos Savopoulos; Georgia Lazaraki; Ioannis Sidiropoulos; Persefoni Haritanti; Anastasios Lefkopoulos; Georgia Karagiannopoulou; Valentini Tzioufa; Koliouskas Dimitrios
Journal:  Indian J Gastroenterol       Date:  2004 Jul-Aug

9.  A study on regression of hypercholesterolemic atherosclerosis in rabbits by flax lignan complex.

Authors:  Kailash Prasad
Journal:  J Cardiovasc Pharmacol Ther       Date:  2007-12       Impact factor: 2.457

10.  Regression of hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed.

Authors:  Kailash Prasad
Journal:  Atherosclerosis       Date:  2007-09-29       Impact factor: 5.162

View more
  2 in total

1.  Effects of vitamin E on serum enzymes and electrolytes in hypercholesterolemia.

Authors:  Kailash Prasad
Journal:  Mol Cell Biochem       Date:  2010-02       Impact factor: 3.396

2.  Nutritional Assessment of Dietary Bt and Cp4EPSPS Proteins on the Serum Biochemical Changes of Rabbits at Different Developmental Stages.

Authors:  Ibrahim B Salisu; Ahmad A Shahid; Qasim Ali; Abdul Q Rao; Tayyab Husnain
Journal:  Front Nutr       Date:  2018-06-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.